Clinical trial
Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or…
NCT00006036 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00006036 |
|---|---|
| Title | Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors |
| Official title | A Phase I Study of NX 211 in Combination With Cisplatin Given as an IV Infusion Days 1, 2, and 3 Every 3 Weeks in Patients With Solid Tumors |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer, Lung Cancer, Ovarian Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | cisplatin, lurtotecan liposome |
| Enrollment | 14 |
| Start date | Mar 22, 2000 |
| Primary completion | Sep 26, 2002 |
| Completion | Dec 21, 2009 |
| First posted | Mar 25, 2004 |
| Last update posted | Apr 6, 2020 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: